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A B S T R A C T
Pseudomonas aeruginosa is an opportunistic pathogen associated with severe diseases, such as cystic fibrosis.
During an extensive search for novel essential genes, we identified tgpA (locus PA2873) in P. aeruginosa PAO1, as
a gene playing a critical role in bacterial viability. TgpA, the translated protein, is an internal membrane protein
with a periplasmic soluble domain, predicted to be endowed with a transglutaminase-like fold, hosting the
Cys404, His448, and Asp464 triad. We report here that Cys404 mutation hampers the essential role of TgpA in
granting P. aeruginosa viability. Moreover, we present the crystal structure of the TgpA periplasmic domain at
1.6 Å resolution as a first step towards structure–activity analysis of a new potential target for the discovery of
antibacterial compounds.
1. Introduction
Infections caused by resistant gram-negative bacteria are becoming
increasingly prevalent, and a serious threat to public health worldwide,
being associated with high morbidity and mortality rates. Colonization
with resistant gram-negative bacteria is common among residents in
long-term care facilities, particularly for patients with an indwelling
device.
Pseudomonas aeruginosa is a gram-negative opportunistic pathogen
responsible for chronic lung colonization in cystic fibrosis patients and
acute infections in hospitals (Driscoll et al., 2007). P. aeruginosa infec-
tions are always difficult to treat due to the natural resistance of this
bacterium (Obritsch et al., 2005), consequently a therapy based on two
or three antimicrobial agents is typically adopted (Lodise et al., 2007;
Szaff et al., 1983; Valerius et al., 1991).
Unravelling novel essential genes or pathways that have not yet
been targeted by clinical antibiotics can foster the development of new
effective antibacterials able to overcome resistance. We previously
discovered that the gene coding for the protein TgpA is essential for P.
aeruginosa viability (Milani et al., 2012). TgpA is a medium size inner
membrane protein (668 amino acids, 74.8 kDa) composed of an N-
terminal domain with 5 transmembrane (TM) helices (residues 11–321
belonging to the DUF3488 superfamily), a periplasmic domain (re-
sidues 180–548), and an additional TM helix (residues 549–567), ter-
minating into a small C-terminal cytoplasmic domain (residues
582–638 belonging to the DUF4129 superfamily). The periplasmic
portion of TgpA was predicted to host an eukaryotic-like transgluta-
minase domain (TG-like domain) (Makarova et al., 1999) of unknown
function, characterized by the presence of a Cys, His, Asp triad, pro-
posed to play a catalytic role. In this work, which represents a con-
tinuation of our published data (Milani et al., 2012), we validate the
available information on the enzyme function both through TgpA point-
mutation and through a 3D structure-based analysis. In particular, we
prove that the triad’s Cys404 residue (Pedersen et al., 1994; Kobayashi
et al., 1998) is required for the essential function of TgpA relative to P.
aeruginosa viability. Furthermore, we present the crystal structure of the
TgpA periplasmic domain at 1.6 Å resolution, solved using the SAD
method. We show that the periplasmic domain is composed of two sub-
domains; one hosts the “catalytic triad” of the TG-like domain, while
the other is structurally linked to carbohydrate binding domains, and
may play a role in substrate binding.
Our results establish P. aeruginosa TgpA as a target suitable for de-
velopment of novel antimicrobial compounds, and provide the struc-
tural bases for such discovery activities.
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2. Results
2.1. Cys404 in the periplasmic TG-like domain is critical for TgpA cell
activity
We previously generated a conditional mutant of P. aeruginosa,
PAO1 PrhaB::tgpA, where genomic TgpA expression is regulated by the
PrhaB promoter (Milani et al., 2012). PAO1 PrhaB::tgpA requires rham-
nose (0.2%) to induce endogenous TgpA expression, and is unable to
grow in the presence of glucose due to PrhaB down-regulation. To assess
whether bacterial viability could be restored by TgpA exogenous ex-
pression, we transformed PAO1 PrhaB::tgpA with a plasmid controlled by
the PBAD promoter, inducible with arabinose (Ara), expressing either
TgpA wt or the C404A mutant.
In the absence of Ara, the PBAD promoter displays a basal activity
resulting in ectopic TgpA expression in PAO1 (Fig. 1A; Table 1).
Interestingly, even such basal amount of ectopic wt TgpA, is able to
compensate the repression of the chromosomal protein, and PAO1
PrhaB::tgpA is able to grow with 1% glucose as well as in the permissive
condition of 0.2% rhamnose (Fig. 1B). On the contrary, the ectopic
expression of the C404A mutant is not able to counterbalance the re-
pression of the endogenous protein, demonstrating that Cys404 is in-
dispensable for the essential function of TgpA (Fig. 1C). Such result
points to a crucial catalytic role of the protein likely involving the
catalytic triad Cys404, His448, and Asp464.
2.2. Crystal structure of the periplasmic domain of TgpA
The recombinant putative TG-like periplasmic domain of TgpA
(residues 180–544 of the full length protein) was expressed in E. coli
BL21 CodonPlus (DE3) as a N-terminal His-tagged protein. After Ni-
IMAC and size-exclusion chromatography purification steps, SDS page
followed by mass spectrometry analysis showed that proteolytic events
had removed about 45 amino acids at the C-terminal end.
Crystallization of this construct (TG-domain) and structure solution,
achieved through the SAD method (based on Hg derivative), produced
interpretable electron density (at 1.6 Å resolution; Table 2) for residues
Val195 through Leu482, i.e. 17 residues upstream of the most probable
proteolytic site at Tyr499.
The TG-domain is folded in a tripartite globular structure (with
average dimensions 50× 45×30 Å3), resembling a heart built by two
sub-domains (right and left ventricles) linked by a central antiparallel β-
sheet composed of four strands (the septum) (Fig. 2A). The right ventricle
subdomain (mostly formed by the N-terminal portion of the TG-do-
main) is primarily composed of β strands, with a major solvent exposed
antiparallel β sheet (6 strands). On the contrary, the left ventricle sub-
domain that, together with the septum, contains the conserved “cata-
lytic triad”, is mainly composed of α-helices. Interestingly, the N-and C-
terminal ends of the TG-domain are located on the same side of the
protein, in agreement with its internal membrane anchoring.
The TgpA residues conserved within the gammaproteobacteria class
(Williams et al., 2010) (excluding pseudomonadales order) can be
grouped in three clusters (Fig. 2C): residues around the active site likely
involved in enzymatic activity (20 amino acids, red sticks), residues
with probable structural function (7 amino acids, blue sticks), and
isolated residues (3 amino acids, orange sticks).
A structure based homology search, over the whole domain and
through the DALI server (Holm and Laakso, 2016) identified two pu-
tative cysteine proteases (pdb-id 3ISR, Z= 9.7, id. 18%; and pdb-id
3KD4, Z= 8.7, id. 17%) from gram-negative bacteria, and the trans-
glutaminase coagulation factor XIII (pdb-id 1L9M (Ahvazi et al., 2002),
Z= 6.2, id. 21%, Fig. S1 for structural comparison). A new search for
similar folds of the C-terminal sub-domain, using the CATH server
(http://www.cathdb.info) (Sillitoe et al., 2015), identified the
pantoate-β-alanine ligase functional family (Pantothenate synthetase 2,
CATH-ID 3.30.1300.10) and the β polymerase domain 2 (class CATH-ID
Fig. 1. Ectopic expression of TgpA wt and C404A. A. Western Blot analysis (His-
tag antibody) of the ectopic expression of the TgpA wt and C404A full-length
proteins in PAO1 with/without arabinose. 10 μl of total membrane fraction
were loaded onto 12% SDS-PAGE; 0.1% Ara samples are diluted 1:10 with re-
spect to the samples without arabinose. B. PAO1 PrhaB::tgpA strains carrying
pHERD28T-TgpA wt or C. pHERD28T-TgpA-C404A, were grown in micro-cul-
tures of 200 µl with the indicated concentrations of rhamnose and glucose.
Cultures growth was monitored in real-time by absorbance measurement at
600 nm (OD600).
Table 1
Relative mRNA levels of ectopically expressed TgpA wt and C404A mutant.
Relative expression a
Strain OD600 0% Ara 0.1% Ara
PAO1-pHERD28T 0.8 1 1
PAO1-pHERD28T-TgpA wt 0.8 16 544
PAO1-pHERD28T-C404A 0.8 11 363
a The calculation of the relative expression of the tgpA gene from plasmid
pHERD28T versus the empty vector was performed as described by the 2−ΔΔCT
method (Livak and Schmittgen, 2001), normalizing first mRNA amounts to 16S
ribosome RNA (ΔCT) and relating the ΔCT in the TgpA wt and C404A mutant
ectopically expressed to the chromosomal copy (ΔΔCT) (PAO1-pHERD28T
Empty vector).
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3.30.460.10), whose members mainly cluster in the phosphotransferase
enzyme family EC 2.7. The identification of a potential phosphate
binding domain is remarkable, considering that we found, in the deri-
vative crystal, a phosphate ion bound close to the active site (see next
section).
Limiting the DALI structural search to the N-terminal portion of the
TG-domain (residues Val195 to Ala323) highlighted structural simi-
larity with different carbohydrate binding domains, such as the chitin
binding domain (chitinase, pdb-id 5DHE (Hanazono et al., 2016),
Z= 2.8, 13% identity), the xylan binding domain (xylanase, pdb-id
1XBD (Simpson et al., 1999), Z= 2.7, 7% identity), and GH52 β-D-
xylosidase (pdb-id 4RHH, Z=3.4, 7% identity), pointing to a possible
involvement of this region in binding to the cell wall peptidoglycan. In
particular, the chitinase domains (ChBD2 and ChBD3) belong to the
carbohydrate binding domain family-II type (IPR001919; CBM2) that is
further classified into two subfamilies according to substrate specifi-
cities: CBM2a that binds cellulose, and CBM2b interacting specifically
with xylan. As for other CBM domains, CBM2 is a β-barrel domain
hosting a planar surface able to bind its ligand(s) via a hydrophobic
strip of aromatic residues.
2.2.1. Active site
As stated in the previous section, we demonstrated that Cys404 is
essential for P. aeruginosa viability and therefore for TgpA catalytic
function. Cys404 is hosted in the C-terminal portion of the periplasmic
domain, forming a typical “catalytic triad” with His448 and Asp464.
While His and Asp side chain positions are restrained by a mutual H-
bond (2.8 Å), Cys404 side chain is H-bonded with main chain nitrogen
of Ala449 (3.4 Å). The environment around Cys404 is characterized by
the presence of both hydrophobic and polar residues, e.g. Ile207,
Tyr380, Phe403, Arg473, and Thr466 (Fig. 2D). Around His448 a net-
work of H-bonds is found involving, besides Asp464, residues Thr466,
Arg473 and Tyr380 bridged by two water molecules and linked to the
main chains of residues Phe445 and Ala447. In this respect, analysis of
the geometry of the “active site” residues Tyr380, Cys404 and His448
using the LabelHash server (Moll et al., 2011) identified structural
homology with the active site of a Cys endopeptidase acting on mur-
opeptides (pdb-id 2HBW (Xu et al., 2009)).
The active Cys404 is buried inside the protein domain at about 10 Å
from the external surface, but it may become fully accessible when the
right substrate is present. The access to the “catalytic triad” cavity is
blocked by a small 310-helix at the C-ter end (residues 478–480;
Fig. 2A) in the crystal structure. A rigid body shift of this short helix, or
its conformational flexibility, would make the putative active site cavity
accessible to substrates. In fact, in the Hg derivative used for SAD
phasing structure (where the mercurial compound is bound to Cys404),
the C-ter end of the protein appears more mobile and the last C-ter
amino acid visible in the electron density is Gln476 (Leu482 in the
native structure; Fig. 2B, grey cartoons), yielding a wider entrance path
to the “active site”. Moreover, in order to accommodate the ethyl-
mercury moiety, Phe403 side chain rotates by ∼135° around its χ1
angle, widening the “active site” cavity (Fig. 2B). Interestingly, besides
the ethyl-mercury moiety, a phosphate ion is hosted within the cavity
(Fig. 2B, red sticks), H-bonded to His268 and Tyr200, with electrostatic
compensation by Arg473 that is in a different conformation with re-
spect to the native structure (Fig. 2B, grey sticks).
A smaller cavity, lined by N-terminal helix amino acids 205–212, is
present in the native structure, where a Cl- ion (present in the protein
buffer) was modelled at 4.9 Å from Cys404 Sγ atom. The putative Cl-
ion interacts with the main chain N-atoms of Gly205, Ile207, Ala208
and Ala405, and to the side chain of His406, partially occupying the
place taken by Phe403 in the derivative structure (Fig. 2B). To sum-
marize, we propose a gating mechanism regulating substrate accessi-
bility to the “active site” that would involve: i) C-terminal helix, ii) N-
ter helix (residues 206–211), and iii) Phe403 double conformation
(Fig. 2B).
2.3. TgpA is able to bind peptidoglycans
As discussed above, structural analysis of the N-terminal portion of
the TG-domain (Val195 – Ala323) suggests structural homology with
different carbohydrate binding domains. Since the major component of
the bacterial cell wall peptidoglycan (PGN) is a complex polymer built
by glycan chains cross-linked through peptide stems and isopeptidic
bonds, we investigated whether the TgpA TG-domain is able to bind to
PGN. To this aim, we performed PGN pull-down assays, where proteins
binding to insoluble PGN fragments co-precipitate with them after
centrifugation.
Pull-down experiments (Fig. 3A) show that the amount of insoluble
TG-domain increases with the concentrations of P. aeruginosa PGN. On
the contrary, the helicase from Dengue virus, used as a negative control,
shows no detectable PGN binding (Fig. 3B), and similar negative results
were obtained using BSA or DNase (data not shown).
To further analyse the TG-domain binding to PGN, we used
Microscale thermophoresis (MST). In particular, we analysed the
binding capability of the TG-domain towards the sacculi from P. aeru-
ginosa or B. subtilis (gram-positive), showing that the protein is able to
bind more efficiently gram-negative PGNs (roughly estimated Kd∼40
and 200 μM, respectively; Fig. 3C). The helicase control binds B. subtilis
PGN with a scarcely significant affinity (Kd∼2mM).
Table 2
X-ray data-collection and refinement statistics.
Data collection TgpA Hg derivative TgpA native
Beam line & wavelength (Å) ESRF BM14U
1.0078 Å
ESRF ID30a-3
0.9677
Space group P43212 P43212
Unit-cell parameters (Å) a=b=72.5;
c= 157.5
a=b=71.6;
c= 164.3
Molecules in a.u. 1 1
Resolution (Å) 48.7–1.8
(1.85–1.80)
43.5–1.6
(1.64–1.60)
Mosaicity (°) 0.2 0.2
Unique reflections 74,217 (5,444)a 57,370 (4,156)b
Completeness (%) 99.9 (99.1) 99.9 (100)
Redundancy 7.1 (3.8) 7.5 (7.8)
Rmeas† (%) 9.1 (127.5) 6.4 (146.8)
CC(1/2) (%) 99.9 (42.5) 99.9 (73.9)
Rpim (%) 2.5 (44.6) 3.2 (68.2)
Anomal. completeness (%) 99.9 (98.8) –
Average I/σ (I) 15.5 (1.1) 17.6 (1.7)
Wilson B-factor (Å2) 31.08 31.23
Final model
R factor‡/Rfree§ (%) 15.6/18.7 (31.5/
30.2)a
16.0/19.4 (30.4/
30.8)b
r.m.s. bonds (Å) 0.015 0.014
r.m.s. angles (°) 1.58 1.81
n. of waters 332 298
Average protein B fac. (Å2) 27.4 28.8
Average solvent B fac. (Å2) 42.0 43.1
Ligand B fac. (Å2) 42.0 –
Residues in most favored
regions (%)
96.9% 96.9%
Residues in additionally allowed
regions (%)
2.7% 2.7%
Ramachandran outlier Glu457 Glu457
PDB-ID 6G4H 6G49
Values in parentheses are for the highest resolution shell:
a (1.85–1.80).
b (1.64–1.60).
† Rmeas= (Σ (n/(n-1) Σ |I−(I)|)/Σ I×100, where I is intensity of a reflec-
tion and (I) is its average intensity.
‡ Rfactor = Σ |Fo− Fc|/Σ |Fo|× 100.
§ Rfree is calculated on 5% randomly selected reflections, for cross-validation.
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3. Discussion
P. aeruginosa is presently considered a public health threat due to its
ability to develop resistance to multiple drugs. A fruitful strategy for the
discovery of new antibiotics relies on the identification of genes that are
essential for bacterial viability. In this context we identified TgpA, an
inner membrane protein as an essential protein for P. aeruginosa, sui-
table for drug development (Milani et al., 2012). Here, we focus on the
analysis of TgpA periplasmic region, predicted to belong to the trans-
glutaminase-like superfamily (TG-like domain), which includes ar-
chaeal, bacterial and eukaryotic proteins homologous to animal trans-
glutaminases (Makarova et al., 1999).
Our structural investigation shows that the periplasmic TG-domain
is composed of two subdomains linked by a central β-sheet (the septum):
the N-ter subdomain, rich of β-strands, likely endowed with regulatory
and/or substrate-binding/recognition activity, and the α-helical C-ter
subdomain, hosting the conserved putative “catalytic triad” Cys404-
His448-Asp464, likely responsible for the enzymatic activity.
In our crystallized TG-domain construct, Cys404 is buried inside the
protein domain at about 10 Å from the closest external surface, due to a
small 310helix that is accommodated on the “catalytic triad” cavity.
Conformational transitions induced by the binding of ethyl-Hg to
Cys404 make the C-ter helix more mobile, leaving the site open and
presumably fully accessible to the correct substrate (when present).
Anyway, we cannot exclude that the location of the C-ter helix may be
the result of construct truncation or of the crystal lattice environment.
In order to test whether the hypothetical catalytic activity of TG-
domain is essential for bacterial viability, we used a modified P. aeru-
ginosa strain with controlled expression of genomic TgpA. We tested
complementation of such strain with either wt TgpA or with the C404A
mutant, showing that only the former is able to rescue the bacterial
growth when the genomic protein is repressed. Such evidences de-
monstrated the crucial role of Cys404 for TgpA activity, suggesting that
the essentiality of TgpA is linked to the TG-domain active site.
The geometry of three residues in the TG-domain active site
(Tyr380, Cys404 and His448) indicates similarity with the active site of
a Cys endopeptidase acting on muropeptides. Moreover, inspection of
the N-terminal portion of the TG-domain (residues Val195 - Ala323)
highlights structural homology with carbohydrate binding domains
able to bind chitin or cellulose (Hanazono et al., 2016; Simpson et al.,
1999). Cellulose, chitin and PGN are major polymers in living organ-
isms, consisting of long-chain carbohydrates linked with β-1,4 glyco-
sidic bonds. Principles and regulatory mechanism of the enzymes in-
volved in the metabolism of these polymers are only partially
understood, however, there is growing structural and biochemical in-
formation on how synthesis, chemical modifications and hydrolysis
processes may occur. In bacteria, there are well-characterized domains
that bind cell wall components, tightly related with enzymes that par-
ticipate in the peptidoglycan degradation and remodelling (Typas et al.,
2011). Considering the periplasmic localization of the protein and the
evidence that the N-ter subdomain is structurally linked to carbohy-
drate binding domains, our structural results suggest a possible in-
volvement of the protein in cell wall (re)modelling. Accordingly, we
proved that the TG-domain is able to interact with PGN using pull-down
experiments. Moreover, with thermophoresis experiments on soluble
portion of PGN extracts, we were able to estimate a rough affinity in the
μM range. Such degree of affinity is in line with the values measured for
the LysM domain (Wong et al., 2014), a well characterized
Fig. 2. TgpA structure. (A) TgpA overall periplasmic domain resembles a heart, represented in cartoons coloured with blue for right ventricle, green for septum, and red
for left ventricle. The catalytic triad is drawn as yellow sticks. (B) TgpA active site and proposed substrate/product gating mechanism involving Phe403: path 1
between the C-ter helix and Arg473, path 2 toward the N-terminal helix. (C) Strictly conserved residues in an alignment performed with members of the gamma-
proteobacteria class (excluding pseudomonadales order; lower sequence identity 45%): residues around the active site represented as red sticks, residues with
structural function coloured in blue, and isolated residues in orange. (D) Active site residues around Cys404 (pictures drawn with PyMOL, The PyMOL Molecular
Graphics System, Version 2.0 Schrödinger, LLC).
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carbohydrate-binding domain with affinity for GlcNac polymers, often
associated with proteins involved in PGN synthesis or remodeling. Al-
though the carbohydrate binding module of the TG-domain does not
share structural homology with LysM or other known PGN binding
domains, the mechanisms supporting PGN recognition are still largely
unknown.
The plasticity of the TG-domain C-ter region, suggested by com-
parison between the native and the Hg-derivative structures, might hint
at a tuning of the protein activity via substrate recognition, with
opening of the active site cleft only when the right substrate is present.
In particular, the structural data suggests a possible gating mechanism
regulating the substrate/product permeability to/from the active site
involving the membrane anchored N- and C-ter regions of the domain
and the double conformation of the side chain of Phe403. Finally, the
phosphate ion observed within the “catalytic triad” cavity when Ethyl-
Hg is covalently bond to Cys404, might suggest preferential selection of
negatively charged substrates.
All the microbiological, structural and biochemical data here re-
ported enrich our views on the function of a new protein essential for P.
aeruginosa viability, thus representing a valuable target for the devel-
opment of novel antibacterial leads.
4. Materials and methods
4.1. Construction of plasmids expressing His-tagged TgpA wt and the
mutant C404A in the full-length protein
A plasmid expressing a His-tagged full length TgpA was prepared by
amplifying the tgpA gene (locus PA2873) from P. aeruginosa PAO1
genomic DNA with primers 5′-TATCATGAACGCGATTCCGCGGGTC-3′
and 5′-AGAAGCTTGTAAAGCTTTCAGTGGTGGTGGTGGTGGTGTGCCT
GCTCCTCTC-3′. Amplicons were digested with BspHI and HindIII re-
striction enzymes and cloned into the broad host range vector
pHERD28T (Qiu et al., 2008), digested with NcoI and HindIII, under the
arabinose inducible promoter PBAD, giving rise to the plasmid
pHERD28T-TgpA.
The QuikChange II XL Kit (Stratagene) was used to generate the
mutant Cys404Ala, using as a template the construct pHERD28T-TgpA,
with the complementary primers carrying the mutated codon 5′- GCG
CAGCGGCTTCGCCGCGCATTACGCC-3′ and 5′-GGCGTAATGCGCGGC
GAAGCCGCTGCGC-3′.
For overexpression, the constructs pHERD28T-TgpA-His and
pHERD28T-C404A-His were moved from E. coli JM109 to PAO1 strain
by triparental mating as described previously (Milani et al., 2012).
PAO1 cells carrying pHERD28T-TgpA-His, pHERD28T-TgpA-C404A-
His, or the pHERD28T empty vector were grown at 37 °C for 20 h in
micro-cultures of 200 µl of LB medium supplemented with 300 µg/ml
Fig. 3. Pull-down experiments with insoluble PGN. The binding capacities of the (A) TG domain and (B) Dengue virus helicase were assayed by pulldown assay with
increasing concentrations of insoluble PGN from P. aeruginosa. The lanes are labelled as follows: MW=Molecular weight marker, P=Pellet, S= Supernatant. (C)
TG domain-PGN interaction analyzed by MST. The TG domain – PGN interaction was monitored by titrating PGN form P. aeruginosa (left) or B. subtilis (right) against
75 nM of TG domain labelled with the Kit RED-NHS (NanoTemper technologies, Munich, Germany). The changes of the fluorescent thermophoresis signals were
plotted and Kd values were estimated using the NanoTemper analysis software, through non linear curve fitting.
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trimethoprim (Tmp) and with increasing arabinose concentrations (0,
0.025, 0.05, 0.1 and 0.2%), for the induction of the PBAD promoter.
Growth cultures were monitored in real-time by absorbance measure-
ment at 600 nm (OD600).
4.2. Western-Blot analysis
Overnight cultures of PAO1/pHERD28T-TgpA-His, PAO1/
pHERD28T-C404A-His and PAO1/pHERD28T in LB medium supple-
mented with 300 µg/ml Tmp were diluted to OD600 of 0.05, incubated
at 37 °C until OD600 of 0.4–0.6 and induced with 0.1% arabinose. A
parallel culture of each strain was grown without the addition of ara-
binose. After two hours induction, the cells were harvested at 7000 rpm
for 10min at 4 °C and the pellet from 100ml of culture was resuspended
in 1ml of lysis buffer (10mM Tris-HCl pH 7.8, 20 μg/ml RNase and
DNase, 1mM PMSF, 0.2 mg/ml lysozyme) and passed through a French
press for cell disruption. The lysates were centrifuged at 5000 rpm for
20min at 4 °C and supernatant was ultracentrifuged at 37,000 rpm for
1 h at 4 °C. The pellets, corresponding to the total membrane fractions,
were resuspended in 200 μl of Tris-HCl pH 7.8. Ten microliters of the
samples with no arabinose and of the samples induced with 0.1% ara-
binose diluted 1:10 were analysed on SDS-PAGE. For Western blot
analysis, specific monoclonal anti-His antibodies (Roche®) in 0.05%
PBS-T were used.
4.3. Quantitative RT-PCR analysis
Total RNA was purified with a Total RNA Extraction kit (RBC
Bioscience). cDNA was generated by incubating 1 μg of RNA with
Superscript II Reverse Transcriptase (RT) (Invitrogen), 100 pg of
random primers and buffer supplied by the manufacturer for 50min at
42 °C. RT was inactivated by incubation at 70 °C for 15min. As a control
of DNA contamination in the subsequent quantitative RT-PCR (qRT-
PCR) analysis, reactions were also run without RT. qRT-PCR amplifi-
cations were performed in duplicate reactions of 15 μl in tubes filled
with iQ™ SYBR Green Supermix (Bio-Rad) and 300 nM of each primer
(see below) and run in an iCycler Real-Time PCR machine (Bio-Rad) as
follows: 1 cycle at 95 °C for 10min, 50 cycles at 95 °C for 15 s and 60 °C
for 40 s. The calculation of the relative expression of the tgpA gene from
plasmid pHERD28T versus the empty vector was performed as de-
scribed by the 2−ΔΔCT method (Livak and Schmittgen, 2001), normal-
izing first mRNA amounts to 16S ribosome RNA (ΔCT) and relating the
ΔCT in the TgpA wt and C404A mutant ectopically expressed to the
chromosomal copy (ΔΔCT) (PAO1-pHERD28T Empty vector). To con-
firm PCR specificity, the PCR products were subjected to melting curve
analysis in a temperature range spanning 55–95 °C with 1 cycle at 55 °C
for 50 s and 80 cycles at 55 °C for 10 s set with 0.5 °C increments after
the first cycle.
The primer pairs used for qRT-PCR were:
tgpA 5′-CGAAAGCGCTCTGCTGCAA-3′/ 5′-TCTTCGCAGTGGTGGT
GGG-3′
16s 5′-tgtcgtcagctcgtgtcgtga-3′/ 5′-atccccaccttcctccggt-3′
4.4. TgpA gene complementation
TgpA wild type (wt) and mutant C404A were tested for their ability
to complement a glucose-mediated down-regulation of the chromo-
somal tgpA gene in the PAO1 PrhaB::tgpA strain (Milani et al., 2012),
when expressed from the ectopic vectors pHERD28T-TgpA or
pHERD28T-TgpA-C404A. For the complementation assays, pHERD28T-
TgpA and pHERD28T-TgpA-C404A were moved from E. coli JM109 to
the conditional mutant PAO1 PrhaB::tgpA strain by triparental mating as
described previously (Milani et al., 2012). Exconjugants PrhaB::tgpA
clones were selected on M9 minimal medium plates supplemented with
0.2% citrate (M9-citrate), 60 µg/ml gentamicin (Gm), 0.2% rhamnose
and 300 µg/ml Tmp. This procedure generated the strains PAO1
PrhaB::tgpA/pHERD28T-TgpA and PAO1 PrhaB::tgpA/pHERD28T-TgpA-
C404.
For both PrhaB::tgpA/pHERD28T-TgpA and PAO1 PrhaB::tgpA/
pHERD28T-TgpA-C404, the conditional growth was assessed after an
overnight growth at 37 °C in M9-citrate supplemented with 60 µg/ml
Gm, 300 µg/ml Tmp and 0.2% rhamnose. An aliquot of the overnight
culture was centrifuged and the bacterial pellet was washed three times
with sterile PBS, and diluted to an OD600 of 10−6 in fresh M9-citrate
with appropriated antibiotics and supplemented either with 0.2%
rhamnose or 1% glucose. 200 µl of the different cultures were grown at
37 °C with stirring and monitored in real time by OD600 measurement in
microtiter reader (TECAN) for 20 hrs.
4.5. Expression and purification of TgpA periplasmic domain
TgpA periplasmic domain (residues 180–544) was expressed in E.
coli BL21CodonPlus (DE3) - RIPL (Agilent; chloramphenicol (Cm) re-
sistance) as N-terminally (His)10-tagged proteins, from plasmid p2N
(PRIMM srl.; ampicillin (Amp) resistance). The cells were grown at
37 °C in 2 l of LB medium containing 100 µg/ml Amp and 34 µg/ml Cm,
to an OD600 of 0.6. After induction with 1mM isopropyl β-D-thioga-
lactopyranoside (IPTG), the incubation temperature was lowered to
17 °C and cells were grown for 16 h. Cells, harvested by centrifugation,
were resuspended in lysis buffer (1x Phosphate buffer saline (PBS), 1%
Triton, 5mM MgCl2, 0.25mg/ml lysozyme, 20 µg/ml DNase, 1µg/ml
Pepstatin A, 0.5mM AEBSF and 1 tablet of complete Protease Inhibitor
(Roche®)), lysed with a cell disruptor (Constant system) at 27 KPSI, and
the soluble fraction was collected after centrifugation at 15,000 rpm for
1 h at 4 °C (Beckman JA20). The protein purification was performed at
4 °C, using a Fast Protein Liquid Chromatography (FPLC) apparatus
(ÄKTA system – GE Healthcare). After Ni-IMAC column (HisTrap™ FF
crude 5ml, GE Healthcare) equilibration with Buffer A (20mM
Phosphate buffer pH 7.5, 500mM NaCl, 0.5 mM AEBSF and 1 tablet of
complete Protease Inhibitor Roche®), the soluble cell extract was loaded
at 1ml/min and eluted at 250mM imidazole. The protein was then
loaded (1ml/min flow-rate) on a Superdex™ 75 column (GE
Healthcare), previously equilibrated with Gel Filtration (GF) Buffer
(20mM Tris-HCl pH 7.5, 500mM NaCl, 20mM imidazole, 0.5 mM
AEBSF and 1 tablet of complete Protease Inhibitor Roche®). During the
expression and purification, the recombinant TgpA periplasmic domain
was susceptible to proteolytic cleavage. Mass analysis confirmed the
loss of more than 40 amino acids at the C-ter end, and the produced
peptides indicated different cleavage sites around Tyr499. The purified
protein (in GF buffer) was concentrated up to 8mg/ml using a cen-
trifugal filter unit (10 kDa cut-off, Millipore).
4.6. Crystal structure TgpA periplasmic domain
Microbatch crystallization experiments on TgpA periplasmic do-
main (6mg/ml) were assembled with an Oryx-8 crystallization robot
(Douglas Instruments, East Garston, UK), with 0.3 µl droplets con-
taining 66/34% of the protein/precipitant solutions, covered with Al's
oil. Crystals were obtained after 48 h at 20 °C, in 0.8M NaH2PO4, 0.8M
KH2PO4, and 0.1M Na HEPES pH 7.5. Before collecting crystals for
flash freezing in liquid nitrogen, about 0.1 µl glycerol was added to the
crystal drop as cryoprotectant. The TgpA native crystals diffracted to a
maximum resolution of 1.6 Å using synchrotron radiation at beam-line
ID30a3 at the European Synchrotron Radiation Facility (ESRF-
Grenoble, France). Additional crystals grown in a different condition
(0.7M (NH4)H2PO4, 0.1M Na HEPES pH 7.2) were selected for soaking
with mercury derivatives. The crystals were soaked in a stabilizing
solution (0.7M (NH4)H2PO4, 0.1M Na HEPES pH 7.6) with 5mM
ethylmercurithiosalicylic acid sodium salt for 60min, then washed (in
stabilizing solution) and transferred into a cryoprotectant solution
(0.7M (NH4)H2PO4, 0.1M Na HEPES pH 7.6, glycerol 25%) and flash
frozen. TgpA derivative crystal showed a nice absorption peak for
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mercury at 12,302 keV (1.0078 Å) and diffracted to a maximum re-
solution of 1.8 Å at beam-line BM14U (ESRF-Grenoble, France). For
both native and derivative crystals, X-ray diffraction data were indexed
and scaled using XDS (Kabsch, 2010) (Table 1).
The three-dimensional structure of TgpA was solved using the SAD
method based on the mercury derivative (X-ray wavelength 1.0078 Å)
using the program package SHELXC/D/E (Sheldrick, 2010) within the
CCP4i interface (Potterton et al., 2003). Briefly, SHELXC detected an
anomalous signal up to∼1.9 Å; SHELXD (at 2 Å resolution) found 6
possible heavy atoms sites (CC All/Weak 42.8/25.1, CFOM 67.9, best
67.9, PATFOM 16.28), and SHELXE calculated the initial phases and
performed density modification (FOM=0.582, Pseudo-free
CC=63.71%). The obtained experimental electron density was then
used to trace an initial protein model with ARP/WARP (Lamzin and
Wilson, 1997). The single TgpA molecule present in the crystal asym-
metric unit was then subjected to manual (program COOT (Emsley
et al., 2010)) and constrained refinements using REFMAC5 (Steiner
et al., 2003), and the partially refined model was used for molecular
replacement to solve the structure of the native dataset (Vagin and
Teplyakov, 1997). Additional refinements with BUSTER (Smart et al.,
2012) and REFMAC5 were subsequently performed for both datasets.
Data collection, refinement statistics as well as stereochemical quality
of the two models (checked also using the wwPDB Validation Server,
https://validate-rcsb-1.wwpdb.org/) are summarized in Table 1 (Read
et al., 2011). Atomic coordinates and structure factors have been de-
posited in the PDB (Berman et al., 2000), with accession codes 6G49
and 6G4H for the native and mercury derivative datasets, respectively.
4.7. Cell wall peptidoglycans isolation
A published method (Desmarais et al., 2014) with minimum mod-
ifications was followed for the isolation of cell wall peptidoglycans
(PGN) from P. aeruginosa. Briefly, cells were harvested from an ex-
ponential phase culture (OD600 of 0.8) by centrifugation, washed two
times with phosphate-buffered saline (PBS). The final pellet was re-
suspended in 3ml of PBS, slowly added to boiling 6% SDS solution and
boiled for 2 h; the mixture was then stirred overnight at room tem-
perature. PNGs were recovered by ultra-centrifugation at 400,000 g,
washed six times with ultrapure water at room temperature and then
digested with 100 μg/ml of Pronase E for 2 h at 60 °C. The reaction was
stopped with the addition of 200 μl of 6% SDS and incubation for
30min at 100 °C. Additional washes by ultra-centrifugation at 400,000
g were performed until the excess of SDS was removed. The final PNGs
were resuspended in 50mM MOPS, pH 7.0 and stored at −20 °C.
4.8. Insoluble peptidoglycan pull down assay
For PGN binding assay, we slightly modified a procedure already
described (Wong et al., 2014). In a 50 μl reaction mixture, 50 μg of
purified TG domain was added to increasing amounts of PGN (25, 50,
100, 200 and 400 μg) in the assay buffer (50mM Tris-HCl, pH 8, 1M
NaCl, 5 mM β-mercaptoethanol, 1% tween-20). The reaction was in-
cubated for 30min at 25 °C, and then centrifuged at 10,500 g for
45min. The supernatant was collected, and the insoluble PGN pellet
was washed three times in assay buffer. Ten microliters of supernatant
and resuspended pellet solution were analysed on a 10% SDS-PAGE gel.
As a reaction control, three different proteins (BSA, DNAse (Sigma) and
helicase from Dengue virus) were used in reaction with the PGN at the
same conditions as TG domain. A negative control was performed with
50 μg of each protein under the same conditions but without PGN, to
ensure that the proteins were not precipitating on their own.
4.9. Cell wall binding affinity
To evaluate the binding ability of the TG domain to cell wall com-
ponents, we used PGN isolated from both Bacillus subtilis (Sigma –
Aldrich) and P. aeruginosa. Protein interactions with PGN were mea-
sured through MicroScale thermophoresis (MST). The soluble fraction
of the sacculi from P. aeruginosa and B. subtilis, was separated from the
insoluble portion by ultracentrifugation (15,000 g), maintaining ∼50%
of the total PGN in the soluble fraction. It is possible to estimate a
hypothetical dissociation constant (Kd) assuming that the binding is due
to the muropeptide glycans N-Acetylglucosamine [GlcNac] and N-
acetylmuramic acid [MurNAc].
Proteins were labelled with the monolith NT™ Protein labelling Kit
RED-NHS (Amine Reactive; NanoTemper technologies, Munich,
Germany) to achieve a 1:1M ratio of labelled protein to dye. Serial
dilutions of the PGN were prepared (from 250 μM to 100 nM) keeping
constant the concentration of labelled TG domain (150 nM), in ther-
mophoresis buffer (50mM Tris/HCl pH 7.4, 150mM NaCl, 10mM
MgCl2, 0.05% Tween-20). MST measurements (MST power 60%) were
performed at 24 °C on a Monolith NT.115 instrument (NanoTemper
Technologies) using Premium coated capillary. As negative control,
helicase from Dengue virus was evaluated for its ability to bind to PGN
from B. subtilis.
The Kd of protein-ligand complexes was then calculated with the
following equation:
= +
+ ++ +
F U
B U ligand protein K
ligand protein K ligand protein
protein
( ) ([ ] [ ]
([ ] [ ] ) 4 [ ] [ ] )
2[ ]
d
d
2
where F indicates the measured fluorescence, while U and B re-
present the response values of the unbound and bound states, respec-
tively.
5. Accession numbers
Coordinates and structure factors have been deposited in the Protein
Data Bank with accession number 6G4H and 6G49.
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